tm
Seeing Is Believing
tm
Seeing Is Believing
VERV is currently covered by 5 analysts with an average price target of $22.27. This is a potential upside of $11.14 (100.09%) from yesterday's end of day stock price of $11.13.
Verve Therapeutics's activity chart (see below) currently has 31 price targets and 38 ratings on display. The stock rating distribution of VERV is 91.67% BUY and 8.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.04% with an average time for these price targets to be met of 15.22 days.
Highest price target for VERV is $15, Lowest price target is $13, average price target is $13.75.
Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 26-Jun-2025. First documented stock forecast 11-Jul-2021.
Currently out of the existing stock ratings of VERV, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$13.5
$2.37 (21.29%)
$30
3 months 20 days ago
(26-Jun-2025)
0/3 (0%)
$2.2 (19.47%)
Buy
$13.5
$2.37 (21.29%)
$25
3 months 29 days ago
(17-Jun-2025)
0/7 (0%)
$2.38 (21.40%)
Buy
$13
$1.87 (16.80%)
$39
4 months ago
(16-Jun-2025)
0/7 (0%)
$1.62 (14.24%)
Hold
$22
6 months 2 days ago
(14-Apr-2025)
1/3 (33.33%)
$9 (69.23%)
8
Buy
$15
$3.87 (34.77%)
$17
7 months 13 days ago
(03-Mar-2025)
0/7 (0%)
$8.83 (143.11%)
What is VERV (Verve Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VERV (Verve Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VERV (Verve Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VERV (Verve Therapeutics)?
Which analyst is the currently most bullish on VERV (Verve Therapeutics)?
Which analyst is the currently most reserved on VERV (Verve Therapeutics)?
